Speech movement measures as markers of bulbar disease in amyotrophic lateral sclerosis
Purpose The goal of this study was to identify the effects of amyotrophic lateral sclerosis
(ALS) on tongue and jaw control, both cross-sectionally and longitudinally. The data were …
(ALS) on tongue and jaw control, both cross-sectionally and longitudinally. The data were …
Lower motor neuron involvement in ALS assessed by motor unit number index (MUNIX): Long-term changes and reproducibility
D Fathi, B Mohammadi, R Dengler, S Böselt… - Clinical …, 2016 - Elsevier
Objective Motor unit number estimation (MUNE) techniques such as motor unit number
index (MUNIX) have been used to quantify lower motor neuron loss and disease …
index (MUNIX) have been used to quantify lower motor neuron loss and disease …
Quantitative voice analysis in the assessment of bulbar involvement in amyotrophic lateral sclerosis
D Robert, J Pouget, A Giovanni, JP Azulay… - Acta oto …, 1999 - Taylor & Francis
Bulbar and pseudobulbar symptoms are diagnostic criteria of amyotrophic lateral sclerosis
(ALS). One of the earliest symptoms of bulbar involvement is voice deterioration. Until now …
(ALS). One of the earliest symptoms of bulbar involvement is voice deterioration. Until now …
Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis
A Hannaford, N Pavey, M van den Bos… - Annals of …, 2021 - Wiley Online Library
Objective The diagnosis of amyotrophic lateral sclerosis (ALS) remains problematic, with
current diagnostic criteria (revised El Escorial [rEEC] and Awaji) being complex and prone to …
current diagnostic criteria (revised El Escorial [rEEC] and Awaji) being complex and prone to …
Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population
OBJECTIVE: Ocular motility abnormalities may be a marker of neuro-degeneration beyond
motor neurons in amyotrophic lateral sclerosis (ALS). We formally compared clinical neuro …
motor neurons in amyotrophic lateral sclerosis (ALS). We formally compared clinical neuro …
Multiple orofacial indices in amyotrophic lateral sclerosis
R DePaul, BR Brooks - Journal of Speech, Language, and Hearing …, 1993 - ASHA
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by significant speech and swallowing problems resulting from upper and …
characterized by significant speech and swallowing problems resulting from upper and …
Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis
R Higo, N Tayama, T Nito - Auris Nasus Larynx, 2004 - Elsevier
Objective: To investigate the progression of dysphagia in amyotrophic lateral sclerosis (ALS)
using videofluoroscopy (VF), according to two different scales: the duration following bulbar …
using videofluoroscopy (VF), according to two different scales: the duration following bulbar …
An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice
IK Gosselt, TCW Nijboer, MA Van Es - … Lateral Sclerosis and …, 2020 - Taylor & Francis
Objective: Patients with amyotrophic lateral sclerosis (ALS) not only show motor deficits, but
may also have cognitive and/or behavioral impairments. Recognizing these impairments is …
may also have cognitive and/or behavioral impairments. Recognizing these impairments is …
The neuropathological signature of bulbar-onset ALS: a systematic review
ALS is a multisystem disorder affecting motor and cognitive functions. Bulbar-onset ALS
(bALS) may be preferentially associated with cognitive and language impairments …
(bALS) may be preferentially associated with cognitive and language impairments …
Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement model
LA Bakker, CD Schröder, MA van Es, P Westers… - Journal of …, 2017 - Springer
The amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R) is a widely
used primary outcome measure in amyotrophic lateral sclerosis (ALS) clinical practice and …
used primary outcome measure in amyotrophic lateral sclerosis (ALS) clinical practice and …